Cargando…
Potential Therapeutic Role for Apelin and Related Peptides in Diabetes: An Update
Type 2 diabetes mellitus (T2DM) is an epidemic with an ever-increasing global prevalence. Current treatment strategies, although plentiful and somewhat effective, often fail to achieve desired glycaemic goals in many people, leading ultimately to disease complications. The lack of sustained efficacy...
Autores principales: | Palmer, Ethan S, Irwin, Nigel, O’Harte, Finbarr PM |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844737/ https://www.ncbi.nlm.nih.gov/pubmed/35177945 http://dx.doi.org/10.1177/11795514221074679 |
Ejemplares similares
-
Proglucagon-Derived Peptides as Therapeutics
por: Lafferty, Ryan A., et al.
Publicado: (2021) -
Long-term treatment with acylated analogues of apelin-13 amide ameliorates diabetes and improves lipid profile of high-fat fed mice
por: O’Harte, Finbarr P. M., et al.
Publicado: (2018) -
Glucagon induces translocation of glucokinase from the cytoplasm to the nucleus of hepatocytes by transfer between 6-phosphofructo 2-kinase/fructose 2,6-bisphosphatase-2 and the glucokinase regulatory protein
por: Cullen, Kirsty S., et al.
Publicado: (2014) -
Xenin and Related Peptides: Potential Therapeutic Role in Diabetes
and Related Metabolic Disorders
por: Craig, Sarah L, et al.
Publicado: (2021) -
Sustained glucagon receptor antagonism in insulin-deficient high-fat-fed mice
por: Lafferty, Ryan A, et al.
Publicado: (2022)